Prolactin Releasing Peptide (1-31)

General biohacking / research

Bioactive effect candidate for Atlas review

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Bioactive compound
Primary mechanism: Mechanism requires verification
Primary market use: General biohacking / research

Pharmacology

Molecular weight (Da): 3664.15
Oral bioavailability: Route-dependent / verify
Half-life: ~5–60 min parent peptide; analogs may be longer
Route tags: SubQ; Injectable; route-dependent
Evidence level: MCE product listing / research chemical signal
Clinical status: Research chemical/reference listing
Value-for-money score: 5 / 10

Reported protocol signal

No clean popular protocol found in uploaded sources; create as research/reference entry and verify before public protocol display.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Prolactin Releasing Peptide (1-31), human is a high affinity GPR10 ligand that cause the release of the prolactin . Prolactin Releasing Peptide (1-31) binds to GPR10 for human and rats with K i values of 1.03 nM and 0.33 nM, respectively. Prolactin Releasing Peptide (1-31) can be used for the research of the hypothalamo-pituitary axis.

Sources

https://www.medchemexpress.com/Prolactin_Releasing_Peptide__1-31_,_human.html